Activation of PDH has thus been proposed as a therapy of interest for metabolic diseases including diabetes (Jeon et al, 2021; Jiang et al, 2019; Le Page et al, 2015; Tabatabaei Dakhili et al, 2023). Here, PDP1 is linked to metabolic disease.